- Home
- SIDU vs CVKD Comparison
SIDU vs CVKD Comparison
Compare SIDU & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIDU
- CVKD
- Stock Information
- Founded
- SIDU 2012
- CVKD 2022
- Country
- SIDU United States
- CVKD United States
- Employees
- SIDU N/A
- CVKD N/A
- Industry
- SIDU Telecommunications Equipment
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- SIDU Telecommunications
- CVKD Health Care
- Exchange
- SIDU Nasdaq
- CVKD Nasdaq
- Market Cap
- SIDU 30.0M
- CVKD 29.5M
- IPO Year
- SIDU 2021
- CVKD 2023
- Fundamental
- Price
- SIDU $2.01
- CVKD $11.37
- Analyst Decision
- SIDU
- CVKD Strong Buy
- Analyst Count
- SIDU 0
- CVKD 1
- Target Price
- SIDU N/A
- CVKD $32.00
- AVG Volume (30 Days)
- SIDU 659.5K
- CVKD 36.4K
- Earning Date
- SIDU 08-18-2025
- CVKD 08-06-2025
- Dividend Yield
- SIDU N/A
- CVKD N/A
- EPS Growth
- SIDU N/A
- CVKD N/A
- EPS
- SIDU N/A
- CVKD N/A
- Revenue
- SIDU $3,860,985.00
- CVKD N/A
- Revenue This Year
- SIDU $144.49
- CVKD N/A
- Revenue Next Year
- SIDU N/A
- CVKD N/A
- P/E Ratio
- SIDU N/A
- CVKD N/A
- Revenue Growth
- SIDU N/A
- CVKD N/A
- 52 Week Low
- SIDU $1.14
- CVKD $5.70
- 52 Week High
- SIDU $7.65
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- SIDU 66.78
- CVKD 39.88
- Support Level
- SIDU $1.71
- CVKD $11.15
- Resistance Level
- SIDU $2.05
- CVKD $12.26
- Average True Range (ATR)
- SIDU 0.11
- CVKD 1.07
- MACD
- SIDU 0.03
- CVKD 0.01
- Stochastic Oscillator
- SIDU 97.44
- CVKD 13.68
About SIDU Sidus Space Inc.
Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.